Solace Therapeutics, Inc. Release: Two Clinical Abstracts On The Vesair Bladder Control System For Treating Stress Urinary Incontinence (SUI) To Be Presented At The American Urogynecology Society(AUGS) Meeting In Denver, CO
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Solace Therapeutics, Inc., announced today that Stefan De Wachter, MD, PhD will be presenting long-term data from the SOLECT Trial and Denise Elser, MD will be presenting a video presentation of the removal and replacement of the Vesair® Bladder Control Balloon during the 37th Annual AUGS Meeting in Denver, Colorado September 28-30th.